Pulsed Electromagnetic Field Therapy (PEMT) in Patients With Degenerative Meniscus Lesions

Launched by AFYONKARAHISAR HEALTH SCIENCES UNIVERSITY · Nov 15, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called Pulsed Electromagnetic Field Therapy (PEMT) for patients with degenerative meniscus lesions in the knee, which can cause pain and affect daily activities. The goal of the study is to see how effective PEMT is at reducing pain and improving the quality of life and knee function for those suffering from this condition.

To be eligible to participate, individuals should have experienced knee pain for at least two months and have MRI results showing meniscus degeneration. They also need to be in good health for rehabilitation and able to follow instructions. However, some people may not be able to join if they have certain conditions, like recent knee treatments, severe arthritis, or specific health issues. Participants can expect to receive PEMT and will be monitored for its effects on their pain and overall knee function. This trial is still in the planning stages and hasn’t started recruiting participants yet.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Knee pain for at least 2 months
• • MRI findings of meniscus degeneration
• • The health condition is suitable for rehabilitation
• • Ability to understand commands
• Exclusion Criteria:
• • Inability to cooperate fully and lack of literacy skills
• • NSAID use
• • Planning pregnancy during pregnancy or treatment process
• • A history of physical therapy and rehabilitation for the knee area in the last 6 months.
• • A history of local injection treatment to the knee area within the last 6 months,
• • A history of trauma, surgery, or fracture in the lower extremity on the side of pain in the last 6 months,
• • Lumbar radiculopathy
• • Presence of advanced gonarthrosis (Kellgren Lawrence stage 3-4)
• • Ligament injury or tear of the knee
• • Systemic inflammatory rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriatic arthritis, vasculitis etc.
• • Neurological diseases (multiple sclerosis, history of cerebrovascular disease, myopathic diseases, epilepsy, febrile convulsions, etc.),
• • Cardiac pacemaker,
• • Malignancy,
• • Bleeding diathesis,
• • An electronic or battery system body implant.
• • Acute infections, presence of tuberculosis